New Medicare Prescription Drug Rebate Rule: Wrong Solution to High Drug Prices

New Medicare Prescription Drug Rebate Rule: Wrong Solution to High Drug Prices

Prescription drug list prices in the United States continue to be a source of frustration for patients and policymakers alike. The administration is pushing forward with new ideas for lower list prices and lower costs for consumers. As the only entity in the prescription drug supply chain whose mission is to lower costs, America’s pharmacy benefit managers support that objective.